Imperva, Inc.

As of September 30, 2018, Imperva, Inc. has 35.15M shares outstanding.

As of September 30, 2018, Imperva, Inc. trades at a trailing price-to-earnings ratio of 58.54. The price-to-sales ratio is 4.57, and the price-to-book ratio stands at -5.98.

As of September 30, 2018, Imperva, Inc. maintains a current ratio of 2.04, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2018. Return on assets (ROA) is negative at -5.02, reflecting losses generated across the asset base. Inventory turnover of 217.22 indicates how many times Imperva, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended September 30, 2018. That works out to an effective tax rate of 29.47, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended September 30, 2018, Imperva, Inc. posted a gross margin of 79.50, reflecting its pricing power and cost economics. The operating margin of -2.78 and net profit margin of -8.00 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2018. Free cash flow yield stands at 5.93, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.28, meaning Imperva, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2018, Imperva, Inc. has an Altman Z-Score of 4.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.